Enquête module démographie et santé (EMDS)
Burkina Faso, 2015
Obtenir les microdonnées
ID de référence
DDI-BFA-INSD-EMDS-2015-v1
Producteur(s)
Institut national de la statistique et de la démographie
Collections
Créé le
May 05, 2025
Dernière modification
May 05, 2025
Consultations
71
Médicaments pour soigner la fièvre/toux (Q538)
Fichier de microdonnées: Enfants de moins de 5 ans Femme
Aperçu
Valide:
1245
Non valide:
0
Type:
Discret
Largeur:
4
Intervalle:
-
Format:
character
Questions et instructions
Catégories
| Valeur | Catégorie | le cas | |
|---|---|---|---|
| ? | 9 |
0.7%
|
|
| A | SP/Fansidar | 8 |
0.6%
|
| ABG | 1 |
0.1%
|
|
| AC | 2 |
0.2%
|
|
| ACX | 1 |
0.1%
|
|
| ADG | 1 |
0.1%
|
|
| AG | 22 |
1.8%
|
|
| AGH | 12 |
1%
|
|
| AGI | 1 |
0.1%
|
|
| AGK | 1 |
0.1%
|
|
| AGX | 1 |
0.1%
|
|
| AH | 2 |
0.2%
|
|
| AHX | 1 |
0.1%
|
|
| AI | 2 |
0.2%
|
|
| AJ | 1 |
0.1%
|
|
| AJX | 2 |
0.2%
|
|
| AK | 1 |
0.1%
|
|
| AX | 11 |
0.9%
|
|
| B | Choloroquine | 6 |
0.5%
|
| BC | 1 |
0.1%
|
|
| BDG | 1 |
0.1%
|
|
| BG | 6 |
0.5%
|
|
| BGH | 2 |
0.2%
|
|
| BH | 1 |
0.1%
|
|
| BI | 4 |
0.3%
|
|
| BX | 4 |
0.3%
|
|
| C | Amodiaquine | 31 |
2.5%
|
| CDG | 1 |
0.1%
|
|
| CDGH | 2 |
0.2%
|
|
| CE | 2 |
0.2%
|
|
| CEG | 1 |
0.1%
|
|
| CEGH | 1 |
0.1%
|
|
| CEHX | 1 |
0.1%
|
|
| CF | 2 |
0.2%
|
|
| CFG | 2 |
0.2%
|
|
| CFGX | 1 |
0.1%
|
|
| CFH | 2 |
0.2%
|
|
| CFX | 3 |
0.2%
|
|
| CG | 40 |
3.2%
|
|
| CGH | 4 |
0.3%
|
|
| CGHX | 2 |
0.2%
|
|
| CGI | 5 |
0.4%
|
|
| CGKX | 1 |
0.1%
|
|
| CGX | 7 |
0.6%
|
|
| CH | 8 |
0.6%
|
|
| CHI | 2 |
0.2%
|
|
| CHX | 7 |
0.6%
|
|
| CI | 9 |
0.7%
|
|
| CX | 25 |
2%
|
|
| D | Quinine | 5 |
0.4%
|
| DG | 3 |
0.2%
|
|
| DHK | 1 |
0.1%
|
|
| DI | 2 |
0.2%
|
|
| DX | 3 |
0.2%
|
|
| E | Artémisinine | 22 |
1.8%
|
| EF | 3 |
0.2%
|
|
| EFG | 2 |
0.2%
|
|
| EFH | 1 |
0.1%
|
|
| EG | 10 |
0.8%
|
|
| EGH | 3 |
0.2%
|
|
| EGHX | 1 |
0.1%
|
|
| EGI | 2 |
0.2%
|
|
| EGX | 4 |
0.3%
|
|
| EH | 7 |
0.6%
|
|
| EHX | 2 |
0.2%
|
|
| EI | 3 |
0.2%
|
|
| EJX | 1 |
0.1%
|
|
| EK | 3 |
0.2%
|
|
| EX | 14 |
1.1%
|
|
| F | Autre anti-paludéen | 21 |
1.7%
|
| FG | 10 |
0.8%
|
|
| FGH | 3 |
0.2%
|
|
| FGHX | 1 |
0.1%
|
|
| FGI | 1 |
0.1%
|
|
| FGX | 5 |
0.4%
|
|
| FH | 1 |
0.1%
|
|
| FHI | 1 |
0.1%
|
|
| FI | 3 |
0.2%
|
|
| FX | 18 |
1.4%
|
|
| G | Antibiotique comprimé/sirop | 283 |
22.7%
|
| GH | 43 |
3.5%
|
|
| GHI | 1 |
0.1%
|
|
| GHX | 10 |
0.8%
|
|
| GI | 17 |
1.4%
|
|
| GIX | 2 |
0.2%
|
|
| GJ | 3 |
0.2%
|
|
| GK | 5 |
0.4%
|
|
| GKX | 1 |
0.1%
|
|
| GX | 50 |
4%
|
|
| H | Antibiotique injection | 16 |
1.3%
|
| HI | 4 |
0.3%
|
|
| HJ | 1 |
0.1%
|
|
| HX | 10 |
0.8%
|
|
| I | Aspirine | 36 |
2.9%
|
| IX | 10 |
0.8%
|
|
| J | Acetaminophen | 0 |
0%
|
| K | Ibuprofen | 2 |
0.2%
|
| KX | 1 |
0.1%
|
|
| X | Autre | 303 |
24.3%
|
| Z | NSP | 28 |
2.2%
|
Attention : ces chiffres indiquent le nombre de cas trouvés dans le fichier de données. Ils ne peuvent être interprétés comme des statistiques sommaires de la population d'intérêt.